Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens

PHASE3CompletedINTERVENTIONAL
Enrollment

499

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
CataractsPresbyopia
Interventions
DEVICE

SBL-3 multifocal intraocular lens

The SBL-3 intraocular lens will be implanted after the cataractous natural lens has been removed, in those patients randomized into this group

DEVICE

Control monofocal intraocular lens

The Control intraocular lens will be implanted after the cataractous natural lens has been removed, in those patients randomized into this group

Trial Locations (13)

17810

The Eye Center of Central PA, Allenwood

18704

Eye Care Specialists, Kingston

29464

Carolina Eyecare Physicians, Mt. Pleasant

33870

Newsom Eye & Laser Center, Sebring

33901

Eye Centers of Florida, Fort Myers

33904

Cape Coral Eye Center, Cape Coral

36301

Eye Center South, Dothan

37072

Loden Vision Center, Goodlettsville

56201

Family Eye Centers, Willmar

76018

Kleiman/Evangelista Eye Center, Arlington

77055

Whitsett Vision Group, Houston

84107

The Eye Institute of Utah, Salt Lake City

93454

Shepard Eye Center, Santa Maria

All Listed Sponsors
lead

Lenstec Incorporated

INDUSTRY

NCT02487160 - Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens | Biotech Hunter | Biotech Hunter